Ethylene glycol monoallyl ether → 4-(1-(2-allyloxyethyl)-1H-benzimidazole-2-carbonyl)piperidine

반응식

O[CH2:2][CH2:3][O:4][CH2:5][CH:6]=[CH2:7].C(OC([N:15]1[CH2:20][CH2:19][CH:18]([C:21]([C:23]2[NH:27][C:26]3[CH:28]=[CH:29][CH:30]=[CH:31][C:25]=3[N:24]=2)=[O:22])[CH2:17][CH2:16]1)=O)(C)(C)C>>[CH2:5]([O:4][CH2:3][CH2:2][N:24]1[C:25]2[CH:31]=[CH:30][CH:29]=[CH:28][C:26]=2[N:27]=[C:23]1[C:21]([CH:18]1[CH2:19][CH2:20][NH:15][CH2:16][CH2:17]1)=[O:22])[CH:6]=[CH2:7]

참가 물질

반응물 2

HCID 8116Ethylene glycol monoallyl ether

HCID 183332351-(t-butoxycarbonyl)-4-(1H-benzimidazole-2-carbonyl)piperidine

생성물 1

HCID 183334304-(1-(2-allyloxyethyl)-1H-benzimidazole-2-carbonyl)piperidine

실험 절차

Prepare by the method of Preparation 4 using allyl hydroxyethyl ether and 1-(t-butoxycarbonyl)-4-(1 H-benzoimidazole-2-carbonyl)-piperidine to give the title compound.

출처 및 근거

ORD 기록: ord-bb6cbbc5fb9a4c35b72528b3efd398f6
출처 데이터셋: uspto-grants-2001_12
DOI: 10.6084/m9.figshare.5104873.v1
특허 번호: US06329392B1

반응 노트

불러오는 중…